IgG-derived Fc down-regulates virus-induced plasmacytoid dendritic cell (pDC) IFNα production

被引:15
作者
Green, DS
Lum, T
Green, JA
机构
[1] No Calif Hlth Care Syst, Dept Vet Affairs, Martinez, CA USA
[2] Univ Calif Davis, Sch Med, Davis, CA 95616 USA
[3] E Bay Inst Res & Educ, Martinez, CA USA
关键词
pDC; IFN alpha; IgG; Fc; HIV; HSV; VSV;
D O I
10.1016/j.cyto.2004.02.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interferon alpha (IFNalpha) produced primarily by plasmacytoid dendritic cells (pDC) is a potent component of the anti-viral innate immune response, and modulates adaptive immunity. Primary control of IFNalpha production occurs at a cellular level and is highly dependent upon regulatory factors and their products. Recent studies have identified up-regulation of IFNalpha production mediated by the adaptive immune response in the form of immune specific IgG. These studies establish a role for the external control of IFNalpha production. The current work demonstrates that the Fc portion of IgG is a potent inhibitor of IFNalpha produced by pDCs in response to HIV, HSV, and VSV. Fc down-regulation occurs after IFNalpha production can be detected by bioassay, and suggests the existence of late regulatory events in the control of IFNalpha production. Down-regulation of IFNalpha is not caused by Fc-induced necrosis, apoptosis or neutralization of IFNalpha activity. Demonstration of Fc-mediated down-regulation of IFNalpha provides additional evidence of the role of IgG in the regulation of IFNalpha production. Published by Elsevier Ltd.
引用
收藏
页码:209 / 216
页数:8
相关论文
共 58 条
[1]  
ANDREW SM, 1995, CURRENT PROTOCOLS IM, P282
[2]   HIV-1 Tat protein stimulates in vivo vascular permeability and lymphomononuclear cell recruitment [J].
Arese, M ;
Ferrandi, C ;
Primo, L ;
Camussi, G ;
Bussolino, F .
JOURNAL OF IMMUNOLOGY, 2001, 166 (02) :1380-1388
[3]   PROTEIN-CONCENTRATION OF LYMPH AND INTERSTITIAL FLUID IN THE RAT TAIL [J].
AUKLAND, K ;
KRAMER, GC ;
RENKIN, EM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1984, 247 (01) :H74-H79
[4]   Intravenous immunoglobulins in the treatment of severe drug eruptions [J].
Bachot, Nicolas ;
Roujeau, Jean-Claude .
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 3 (04) :269-274
[5]   On the role of IRF in host defense [J].
Barnes, B ;
Lubyova, B ;
Pitha, PM .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2002, 22 (01) :59-71
[6]   THE INTERFERONS - MECHANISMS OF ACTION AND CLINICAL-APPLICATIONS [J].
BARON, S ;
TYRING, SK ;
FLEISCHMANN, WR ;
COPPENHAVER, DH ;
NIESEL, DW ;
KLIMPEL, GR ;
STANTON, GJ ;
HUGHES, TK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (10) :1375-1383
[7]   Passive immunotherapy in advanced HIV infection and therapeutic plasmapheresis in asymptomatic HIV-positive individuals: a four-year clinical experience [J].
Blick, G ;
Scott, WF ;
Crook, SW ;
Buchanan, S ;
Garton, T ;
Hopkins, U ;
Vadaboncoeur, AM ;
Doolittle, J ;
Bulcraig, IA ;
Greiger-Zanlungo, P ;
Karpas, A .
BIOTHERAPY, 1998, 11 (01) :7-14
[8]   Antibodies, viruses and vaccines [J].
Burton, DR .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (09) :706-713
[9]   Molecular virology and immunology of HIV infection [J].
Chinen, J ;
Shearer, WT .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 110 (02) :189-198
[10]   Regulation of virus-induced interferon-A genes [J].
Civas, A ;
Island, ML ;
Génin, P ;
Morin, P ;
Navarro, S .
BIOCHIMIE, 2002, 84 (07) :643-654